Cancer Talk

Fumito Ito, MD, PhD, FACS
News

Optimizing Immunotherapy: Roswell Park Identifies Promising Biomarker of Response to Checkpoint Inhibitors

In a talk to be presented online as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting II, Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center will highlight new evidence that a biomarker for predicting response to checkpoint inhibitors in patients with lung cancer exists and can be detected through a blood test
a family ride their bikes in the Ride for Roswell
News

The Ride for Roswell Announces Locations for the Summer of the Ride

The Ride for Roswell, presented by the West Herr Automotive Group, is excited to announce the locations and details for its in-person, scheduled, physically distant rides that are the features of this year’s Summer of the Ride. There will be four locations with five distances on six days this August.
BRCA Mutation illustration
Article

What is the Difference Between BRCA1 and BRCA2?

BRCA1 and BRCA2 are tumor suppressor genes, meaning when they function normally their job is to keep tumors from forming. Some people however, have an altered or mutated copy of the gene and certain mutations are associated with an increased risk for several cancer types, including breast, ovarian, prostate, pancreatic, melanoma, and in some families, colorectal.
Cancer Support
News

Roswell Park Deputy Director Picked as Board Member for Influential Immunotherapy Organization

Elected by a body of fellow immunotherapy researchers from across the globe, Roswell Park Comprehensive Cancer Center Deputy Director Kunle Odunsi, MD, PhD, FRCOG, FACOG, has been named an At-Large Director for the Society for Immunotherapy of Cancer (SITC) Board of Directors. The nonprofit organization’s members voted for Dr. Odunsi during their election in May. He will begin his three-year term in January 2021.
Lymphoma on the skin
Article

Can Lymphoma Develop on the Skin?

Your skin can be the site of a type of cancer called cutaneous T-cell lymphoma (CTCL), which can look like eczema or psoriasis, causing scaly or itchy lesions and plaques that cause irritation.
Cancer Support